{"title":"褪黑激素与咪达唑仑对儿童口服预用药的疗效:一项系统回顾和荟萃分析。","authors":"Vrushali C Ponde, Neha Singh, Anuya Gursale, Anagha Patil, Airu Chia, Harikrishna Balasubramanian, Balakrishnan Ashokka","doi":"10.23736/S2724-5276.24.07519-0","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Achieving appropriate levels of premedication and parental separation is needed for smooth induction of anesthesia and prevention of perioperative complications. Both melatonin and midazolam are used for the premedication in children, but we do not have consensus on which premedication is superior among them.</p><p><strong>Evidence acquisition: </strong>A systematic review of randomized controlled trials comparing the efficacy and safety of use of midazolam and melatonin as premedication in children aged 1-15 years was conducted. Patients who received drugs other than melatonin or midazolam as premedication were excluded. PubMed, Embase, Scopus, Google Scholar were searched and the last search was done in December 2022.</p><p><strong>Evidence synthesis: </strong>Full text of ten articles with a total of 774 participants (442 melatonin, 332 midazolam) were eligible. The data extracted were synthesized after quality assessment. The outcomes appraised included: sedation, anxiety in preoperative room and during induction. Among four studies examining sedation, there were no significant differences between melatonin and midazolam (SMD=0.03, 95% CI - 0.35 to 0.40, P=0.88, I<sup>2=</sup>81%). There were no significant differences between melatonin and midazolam among two studies examining anxiety in pre-operative room (SMD=-0.04, 95% CI -4.58,4.50, P=0.99, I<sup>2=</sup>0%) and anxiety during anesthesia induction as an outcome (SMD=-1.38, 95% CI -4.81 to 2.05, P=0.43, I<sup>2=</sup>0%).</p><p><strong>Conclusions: </strong>The review showed that melatonin is comparable to midazolam in achieving sedation for facilitating inhalational induction in pediatric patients. The review showed no significant difference in reduction of anxiety in the preoperative room and during induction of anesthesia when either melatonin or midazolam is used as premedicants. Heterogeneity in premedication doses, parameters assessed, outcomes measured, and scales that quantify efficacy resulted in the inconsistencies in how the medications were compared and hence resulted in difficulties in data synthesis. Future studies comparing efficacy of premedication need to consider the proposed standardizations in methodology for achieving optimal results that are a fair comparison of the two medications.</p>","PeriodicalId":56337,"journal":{"name":"Minerva Pediatrics","volume":" ","pages":"94-104"},"PeriodicalIF":1.0000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Efficacy of melatonin vs. midazolam for oral premedication in children: a systematic review and meta-analysis.\",\"authors\":\"Vrushali C Ponde, Neha Singh, Anuya Gursale, Anagha Patil, Airu Chia, Harikrishna Balasubramanian, Balakrishnan Ashokka\",\"doi\":\"10.23736/S2724-5276.24.07519-0\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Achieving appropriate levels of premedication and parental separation is needed for smooth induction of anesthesia and prevention of perioperative complications. Both melatonin and midazolam are used for the premedication in children, but we do not have consensus on which premedication is superior among them.</p><p><strong>Evidence acquisition: </strong>A systematic review of randomized controlled trials comparing the efficacy and safety of use of midazolam and melatonin as premedication in children aged 1-15 years was conducted. Patients who received drugs other than melatonin or midazolam as premedication were excluded. PubMed, Embase, Scopus, Google Scholar were searched and the last search was done in December 2022.</p><p><strong>Evidence synthesis: </strong>Full text of ten articles with a total of 774 participants (442 melatonin, 332 midazolam) were eligible. The data extracted were synthesized after quality assessment. The outcomes appraised included: sedation, anxiety in preoperative room and during induction. Among four studies examining sedation, there were no significant differences between melatonin and midazolam (SMD=0.03, 95% CI - 0.35 to 0.40, P=0.88, I<sup>2=</sup>81%). There were no significant differences between melatonin and midazolam among two studies examining anxiety in pre-operative room (SMD=-0.04, 95% CI -4.58,4.50, P=0.99, I<sup>2=</sup>0%) and anxiety during anesthesia induction as an outcome (SMD=-1.38, 95% CI -4.81 to 2.05, P=0.43, I<sup>2=</sup>0%).</p><p><strong>Conclusions: </strong>The review showed that melatonin is comparable to midazolam in achieving sedation for facilitating inhalational induction in pediatric patients. The review showed no significant difference in reduction of anxiety in the preoperative room and during induction of anesthesia when either melatonin or midazolam is used as premedicants. Heterogeneity in premedication doses, parameters assessed, outcomes measured, and scales that quantify efficacy resulted in the inconsistencies in how the medications were compared and hence resulted in difficulties in data synthesis. Future studies comparing efficacy of premedication need to consider the proposed standardizations in methodology for achieving optimal results that are a fair comparison of the two medications.</p>\",\"PeriodicalId\":56337,\"journal\":{\"name\":\"Minerva Pediatrics\",\"volume\":\" \",\"pages\":\"94-104\"},\"PeriodicalIF\":1.0000,\"publicationDate\":\"2025-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Minerva Pediatrics\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.23736/S2724-5276.24.07519-0\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/12/2 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"PEDIATRICS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Minerva Pediatrics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.23736/S2724-5276.24.07519-0","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/12/2 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"PEDIATRICS","Score":null,"Total":0}
引用次数: 0
摘要
前言:实现适当水平的用药前和父母分离是顺利诱导麻醉和预防围手术期并发症的必要条件。褪黑素和咪达唑仑都被用于儿童的预用药,但我们对其中哪种预用药更优尚未达成共识。证据获取:对随机对照试验进行了系统评价,比较了咪达唑仑和褪黑素作为1-15岁儿童前用药的有效性和安全性。接受褪黑激素或咪达唑仑以外药物作为前用药的患者被排除在外。检索PubMed, Embase, Scopus, b谷歌Scholar,最后一次检索是在2022年12月。证据合成:10篇文章的全文,共有774名参与者(442名褪黑激素,332名咪达唑仑)符合条件。提取的数据经质量评价后进行综合。评估的结果包括:镇静,术前和引产时的焦虑。在4项关于镇静作用的研究中,褪黑激素与咪达唑仑之间无显著差异(SMD=0.03, 95% CI - 0.35 ~ 0.40, P=0.88, I2=81%)。在两项以术前焦虑(SMD=-0.04, 95% CI -4.58,4.50, P=0.99, I2=0%)和麻醉诱导期间焦虑作为结果的研究中,褪黑素和咪达唑仑无显著差异(SMD=-1.38, 95% CI -4.81至2.05,P=0.43, I2=0%)。结论:该综述显示,褪黑素在促进儿科患者吸入诱导的镇静作用上与咪达唑仑相当。回顾显示,在术前和麻醉诱导期间,使用褪黑激素或咪达唑仑作为前药,在减少焦虑方面没有显著差异。用药前剂量、评估的参数、测量的结果和量化疗效的量表的异质性导致了药物比较方式的不一致,从而导致了数据合成的困难。未来比较用药前疗效的研究需要考虑提出的标准化方法,以实现两种药物公平比较的最佳结果。
Efficacy of melatonin vs. midazolam for oral premedication in children: a systematic review and meta-analysis.
Introduction: Achieving appropriate levels of premedication and parental separation is needed for smooth induction of anesthesia and prevention of perioperative complications. Both melatonin and midazolam are used for the premedication in children, but we do not have consensus on which premedication is superior among them.
Evidence acquisition: A systematic review of randomized controlled trials comparing the efficacy and safety of use of midazolam and melatonin as premedication in children aged 1-15 years was conducted. Patients who received drugs other than melatonin or midazolam as premedication were excluded. PubMed, Embase, Scopus, Google Scholar were searched and the last search was done in December 2022.
Evidence synthesis: Full text of ten articles with a total of 774 participants (442 melatonin, 332 midazolam) were eligible. The data extracted were synthesized after quality assessment. The outcomes appraised included: sedation, anxiety in preoperative room and during induction. Among four studies examining sedation, there were no significant differences between melatonin and midazolam (SMD=0.03, 95% CI - 0.35 to 0.40, P=0.88, I2=81%). There were no significant differences between melatonin and midazolam among two studies examining anxiety in pre-operative room (SMD=-0.04, 95% CI -4.58,4.50, P=0.99, I2=0%) and anxiety during anesthesia induction as an outcome (SMD=-1.38, 95% CI -4.81 to 2.05, P=0.43, I2=0%).
Conclusions: The review showed that melatonin is comparable to midazolam in achieving sedation for facilitating inhalational induction in pediatric patients. The review showed no significant difference in reduction of anxiety in the preoperative room and during induction of anesthesia when either melatonin or midazolam is used as premedicants. Heterogeneity in premedication doses, parameters assessed, outcomes measured, and scales that quantify efficacy resulted in the inconsistencies in how the medications were compared and hence resulted in difficulties in data synthesis. Future studies comparing efficacy of premedication need to consider the proposed standardizations in methodology for achieving optimal results that are a fair comparison of the two medications.